Table 1.
Clinicopathological characteristics of patient samples and expression of transducin (β)-like 1 X-linked receptor 1 in breast cancer
| Number of cases (%) | |
|---|---|
| Gender | |
| Male | 0 (0.0) |
| Female | 214 (100.0) |
| Age, years | |
| ≤47 | 101 (47.2) |
| >47 | 113 (52.8) |
| Clinical stage | |
| I | 21 (9.8) |
| II | 107 (50.0) |
| III | 66 (30.8) |
| IV | 20 (9.3) |
| Tumor (T) classification | |
| T1 | 69 (32.3) |
| T2 | 113 (52.8) |
| T3 | 24 (11.2) |
| T4 | 8 (3.7) |
| Node (N) classification | |
| N0 | 67 (31.3) |
| N1 | 80 (37.4) |
| N2 | 63 (29.4) |
| N3 | 4 (1.9) |
| Metastasis (M) classification | |
| No | 192 (89.7) |
| Yes | 22 (10.3) |
| Vital status at follow up | |
| Alive | 146 (68.2) |
| Dead | 68 (31.8) |
| Histological differentiation | |
| Well-differentiated | 8 (3.7) |
| Moderately differentiated | 152 (71.0) |
| Poorly differentiated | 54 (25.3) |
| Expression of transducin (β)-like 1 X-linked receptor 1 | |
| Low expression | 103 (48.1) |
| High expression | 111 (51.9) |
| Detectable | 214 (100.0) |
| Undetectable | 0 (0.0) |
| Expression of estrogen receptor | |
| 0 | 91 (42.6) |
| 1 | 98 (45.8) |
| 2 | 14 (6.5) |
| 3 | 11 (5.1) |
| Expression of progesterone receptor | |
| 0 | 76 (35.5) |
| 1 | 99 (46.3) |
| 2 | 27 (12.6) |
| 3 | 11 (5.1) |
| 4 | 1 (0.5) |
| Expression of c-erbB2 | |
| 0 | 36 (16.8) |
| 1 | 33 (15.4) |
| 2 | 29 (13.6) |
| 3 | 14 (6.5) |
| 4 | 3 (1.4) |